Evaluation of Metabolic Changes in Acute Intermittent Porphyria Patients by Targeted Metabolomics

• Published in: International journal of molecular sciences Vol. 23; no. 6; p. 3219
• Main Authors: Gomez-Gomez, Alex, Aguilera, Paula, Langohr, Klaus, Casals, Gregori, Pavon, Cristina, Marcos, Josep, To-Figueras, Jordi, Pozo, Oscar J
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 16-03-2022; MDPI
• Subjects: Abnormalities; acute intermittent porphyria; Amino acids; Aminolevulinic acid; Aminolevulinic Acid - urine; Biomarkers; Biosynthesis; Chromatography, Liquid; Discriminant analysis; Disease; Enzymes; Fumaric acid; Heme; Hepatocytes; Homocysteine; Humans; In vivo methods and tests; Kynurenine; LC-MS/MS; Liquid chromatography; Liver; Mass spectrometry; Mass spectroscopy; Metabolic pathways; Metabolism; Metabolites; Metabolomics; Mitochondria; Mutation; Plasma; Porphyria; Porphyria, Acute Intermittent; Steroids; Succinic Acid; Tandem Mass Spectrometry; Tricarboxylic acid cycle; Tryptophan; LC-MS/MS; tricarboxylic acid cycle; kynurenine; acute intermittent porphyria; metabolomics; tryptophan
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23063219

Acute intermittent porphyria (AIP) is an inherited rare hepatic disorder due to mutations within the hydroxymethylbilane gene. AIP patients with active disease overproduce aminolevulinic acid (ALA) and porphobilinogen (PBG) in the liver which are exported inducing severe neurological attacks. Different hepatic metabolic abnormalities have been described to be associated with this condition. The goal of this research was to explore the metabolome of symptomatic AIP patients by state-of-the art liquid chromatography-tandem mass spectrometry (LC-MS/MS). A case versus control study including 18 symptomatic AIP patients and 33 healthy controls was performed. Plasmatic levels of 51 metabolites and 16 ratios belonging to four metabolic pathways were determined. The results showed that the AIP patients presented significant changes in the two main areas of the metabolome under study: (a) the tryptophan/kynurenine pathway with an increase of tryptophan in plasma together with increase of the kynurenine/tryptophan ratio; and (b) changes in the tricarboxylic acid cycle (TCA) including increase of succinic acid and decrease of the fumaric acid/succinic acid ratio. We performed a complementary in vitro study adding ALA to hepatocytes media that showed some of the effects on the TCA cycle were parallel to those observed in vivo. Our study confirms in plasma previous results obtained in urine showing that AIP patients present a moderate increase of the kynurenine/tryptophan ratio possibly associated with inflammation. In addition, it also reports changes in the mitochondrial TCA cycle that, despite requiring further research, could be associated with an energy misbalance due to sustained overproduction of heme-precursors in the liver.